Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.

Item
http://www.wikidata.org/entity/Q37170062
Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidateNew developments in anti-malarial target candidate and product profilesDeveloping transmission-blocking strategies for malaria control.Efficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis.An N-terminal Pfs230 domain produced in baculovirus as a biological active transmission-blocking vaccine candidate.Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate.Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.Peptide data on the disulfide bond analysis of baculovirus produced Pfs25 by LC-MSMS.
P2860

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.

Item
http://www.wikidata.org/entity/Q37170062
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@en
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@nl
type
label
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@en
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@nl
prefLabel
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@en
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
Assessment of Pfs25 expressed ...... n-blocking vaccine candidates.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932